Loyal raised a $100M Series C, led by age1, to advance its canine longevity drug.
- Amount
- $100M
- Stage
- Series C
- Announced
- 11 February 2026
- Lead
- age1
- Other investors
- Baillie Gifford
- Use of funds
- scale its team, build distribution channels, and prepare for market launch of the first drug to extend canine lifespan
- Total raised
- $250M to date
- Checked
- Amount and date checked against the press source